Pro Medicus Limited (PMCUF)
OTCMKTS · Delayed Price · Currency is USD
195.23
0.00 (0.00%)
Oct 6, 2025, 8:00 PM EDT
Pro Medicus Revenue
In the fiscal year ending June 30, 2025, Pro Medicus had annual revenue of 212.98M AUD with 31.88% growth. Pro Medicus had revenue of 115.79M in the half year ending June 30, 2025, with 70.25% growth.
Revenue
212.98M AUD
Revenue Growth
+31.88%
P/S Ratio
148.03
Revenue / Employee
1.61M AUD
Employees
132
Market Cap
20.67B USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 212.98M | 51.48M | 31.88% |
Jun 30, 2024 | 161.50M | 36.60M | 29.30% |
Jun 30, 2023 | 124.90M | 31.44M | 33.64% |
Jun 30, 2022 | 93.46M | 25.40M | 37.31% |
Jun 30, 2021 | 68.06M | 11.24M | 19.79% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
Nuo Therapeutics | 1.95M |
Pro Medicus News
- 10 days ago - ASX 200 news from Monday 29th September 2025: Shares gain; Synlait sells North Island assets to Abbott; Novonix delivers mass-production; Pro Medicus unaffected by US tariffs. Follow live here. - The Australian Financial Review
- 12 days ago - Fortescue tops list of the ASX’s 10 strongest dividend stocks - The Australian Financial Review
- 5 weeks ago - ASX 200 Live: ASX wavers; RPMGlobal soars 25pc on Caterpillar deal, Fortescue trades ex-dividend - The Australian Financial Review
- 5 weeks ago - How this fundie used AI to short Guzman y Gomez – and won - The Australian Financial Review
- 7 weeks ago - Pro Medicus Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - What we learnt: Telstra boss Vicki Brady has achieved something that has eluded many big companies since the pandemic - The Australian Financial Review
- 2 months ago - Pro Medicus full-year profit surges 40pc on contract wins - The Australian Financial Review